How Many Units Is 2.5 mg of Tirzepatide? (Conversion Chart)

Tirzepatide mg-to-units and units-to-mg charts for every dose and common vial concentration, plus how to read your syringe.

By

NativeMed

Medically reviewed by

Dr. Constantin Chikando, MD

Published

· Last reviewed

Conversion card showing 2.5 mg of tirzepatide equals 50, 25 or 12.5 units at 5, 10 and 20 mg/mL

Key Takeaways

  • 2.5 mg of tirzepatide is 25 units at 10 mg/mL, 50 units at 5 mg/mL and 12.5 units at 20 mg/mL.

  • mg to units: dose in mg ÷ concentration in mg/mL × 100. Units to mg: units ÷ 100 × concentration.

  • Concentration varies by pharmacy and can change with a new vial, so check your label every time.

  • Branded Zepbound pens and single-dose vials don't need conversion. Units only apply to multi-dose vials.

2.5 mg of tirzepatide is 25 units on a U-100 insulin syringe if your vial's concentration is 10 mg/mL. At other concentrations the number changes: 50 units at 5 mg/mL, and 12.5 units at 20 mg/mL. Your vial label shows its concentration, and that's the number to use.

This page has the conversion tables for every common dose, a reverse table for turning units back into mg, and how to read your syringe.

Important: this is general information. Always follow your prescription label and your provider's instructions. If your numbers don't match what you expect, ask your provider or pharmacist before injecting.

The formula

A U-100 insulin syringe holds 100 units per milliliter (mL), so 1 unit is 0.01 mL. To convert:

  • mg to units: dose in mg ÷ concentration in mg/mL × 100

  • units to mg: units ÷ 100 × concentration in mg/mL

Example: your vial says 10 mg/mL and your dose is 2.5 mg. That's 2.5 ÷ 10 × 100 = 25 units.

How many units is 2.5 mg of tirzepatide?

2.5 mg of tirzepatide in units, by vial concentration

Vial concentration

Units for 2.5 mg

Amount (mL)

5 mg/mL

50 units

0.5 mL

8 mg/mL

31.25 units (about 31)

0.31 mL

10 mg/mL

25 units

0.25 mL

12.5 mg/mL

20 units

0.2 mL

15 mg/mL

16.7 units (about 17)

0.17 mL

20 mg/mL

12.5 units

0.125 mL

When the math gives a fraction of a unit, ask your provider or pharmacist how to round it for your syringe. Don't guess.

Tirzepatide mg to units: every standard dose

Tirzepatide mg to units on a U-100 syringe

Dose

5 mg/mL

10 mg/mL

20 mg/mL

2.5 mg

50 units

25 units

12.5 units

5 mg

100 units

50 units

25 units

7.5 mg

150 units*

75 units

37.5 units

10 mg

200 units*

100 units

50 units

12.5 mg

250 units*

125 units*

62.5 units

15 mg

300 units*

150 units*

75 units

*More than one 100-unit syringe.

For the week-by-week schedule these doses follow, see the tirzepatide dosage chart.

Tirzepatide units to mg

If you know how many units you draw and want to check the dose, use this table:

Tirzepatide units to mg, by vial concentration

Units

5 mg/mL

10 mg/mL

20 mg/mL

10 units

0.5 mg

1 mg

2 mg

25 units

1.25 mg

2.5 mg

5 mg

50 units

2.5 mg

5 mg

10 mg

75 units

3.75 mg

7.5 mg

15 mg

100 units

5 mg

10 mg

20 mg

How to read your vial label

Your vial label shows two different numbers, and mixing them up is the most common cause of dosing mistakes:

  • Concentration is how much tirzepatide is in each mL of liquid, for example 10 mg/mL. It describes the vial and stays the same for the whole vial.

  • Your dose is how much tirzepatide you take each week, for example 2.5 mg. It comes from your prescription and changes as your provider adjusts it.

If your pharmacy changes, check the concentration again. A new vial can have a different concentration, which changes how many units you draw for the same dose.

What your medication should look like: a reddish color means your vial contains the B12 additive, and a clear liquid means it does not. Both are normal. If the liquid is cloudy, has particles, or doesn't match your prescription, stop and contact support.

How to read your syringe

U-100 insulin syringes come in three common sizes, and their markings differ:

U-100 insulin syringe sizes

Syringe size

Holds up to

Each small line

0.3 mL

30 units

1 unit (some show half units)

0.5 mL

50 units

1 unit

1 mL

100 units

2 units

Check which syringe you have before you draw, because the same mark can mean a different number of units on a different size.

Measure carefully. A small misreading can cause a large dosing error. FDA has received reports of patients drawing 50 units instead of 5. If you are unsure, ask your provider or pharmacist before injecting.

Do branded pens and vials use units?

No. Zepbound pens and single-dose vials are made for one fixed dose each, so you don't convert anything. You only need units when you draw a dose from a multi-dose vial, which is how compounded tirzepatide is usually supplied.

Handling your vial

Use a new needle and syringe for every dose. Discard the vial by the date from your pharmacy or 28 days after first use, whichever comes first. If your medication arrives warm, contact the pharmacy or support before using it.

If you take too much

Extra medication most often causes mild stomach side effects. If nausea, vomiting or abdominal discomfort keeps getting worse, go to urgent care because this can be pancreatitis. Never double up on doses. If you believe you took more than prescribed, contact your healthcare provider promptly. You may also contact Poison Control at 1-800-222-1222. For severe or life-threatening symptoms, call 911 or seek emergency medical attention.

For other side effects and warning signs, see tirzepatide side effects.

Tirzepatide at NativeMed

At NativeMed, a licensed U.S. provider reviews your health history and decides whether compounded tirzepatide is appropriate for you. Before treatment, you'll be asked to give your consent to treatment with a compounded medication. If it's prescribed, your label shows your vial's concentration and your dose, and your care team can help if anything is unclear.

Plans start from $183 a month, at the same price for any dose. See compounded tirzepatide plans.

Compounded medications are not approved by the FDA, and the FDA does not review them for safety, effectiveness or quality before they are dispensed. Individual results vary. Read the full Important Safety Information.

Frequently asked questions

How many units is 2.5 mg of tirzepatide?

It depends on your vial's concentration. At 10 mg/mL, 2.5 mg is 25 units on a U-100 insulin syringe. At 5 mg/mL it is 50 units, and at 20 mg/mL it is 12.5 units.

How many units is 5 mg of tirzepatide?

At 10 mg/mL, 5 mg is 50 units. At 5 mg/mL it is 100 units, and at 20 mg/mL it is 25 units.

How many mg is 50 units of tirzepatide?

At 10 mg/mL, 50 units is 5 mg. At 5 mg/mL it is 2.5 mg, and at 20 mg/mL it is 10 mg.

What size syringe should I use for tirzepatide?

Use the U-100 insulin syringe your pharmacy or provider recommends. A 0.3 mL or 0.5 mL syringe makes small doses easier to measure, because each line is 1 unit instead of 2.

What if my concentration isn't in the chart?

Use the formula: dose in mg ÷ concentration in mg/mL × 100. If you're unsure of the result, ask your provider or pharmacist before injecting.

Dr. Constantin Chikando, MD, Board-Certified Emergency Medicine Physician

Medically reviewed by

Dr. Constantin Chikando, MD

Board-Certified Emergency Medicine Physician

Limited time discount on

your first order

Sign up to receive health tips and more.

NativeMed may facilitate access to compounded medications when prescribed by a licensed healthcare provider and dispensed by a licensed compounding pharmacy. Compounded medications are not approved by the U.S. Food and Drug Administration (FDA), and the FDA does not review compounded medications for safety, effectiveness, or quality before they are dispensed. Compounded medications are prepared for individual patients based on a provider’s medical judgment and are not generic versions of, therapeutically equivalent to, or substitutes for FDA-approved medications such as MOUNJARO®, ZEPBOUND™, Wegovy®, or Ozempic®. NativeMed does not manufacture medications, practice medicine, or determine whether a specific medication is appropriate for you. Treatment decisions are made by licensed healthcare providers after reviewing your medical history, eligibility, and treatment goals. Information provided by NativeMed is for educational purposes only and should not be interpreted as a claim that any compounded medication is FDA-approved, clinically proven, equivalent to an FDA-approved drug, or guaranteed to produce a specific result, including weight loss. Individual results vary. All medications carry risks, potential side effects, and contraindications and should be used only as prescribed under the supervision of a licensed healthcare provider.

IMPORTANT SAFETY INFORMATION

Copyright © 2026 NativeMed

|

All Rights Reserved

|

|

|

|

|

|

|

|

Limited time discount

on

your first order

Sign up to receive health tips and more.

|

NativeMed may facilitate access to compounded medications when prescribed by a licensed healthcare provider and dispensed by a licensed compounding pharmacy. Compounded medications are not approved by the U.S. Food and Drug Administration (FDA), and the FDA does not review compounded medications for safety, effectiveness, or quality before they are dispensed. Compounded medications are prepared for individual patients based on a provider’s medical judgment and are not generic versions of, therapeutically equivalent to, or substitutes for FDA-approved medications such as MOUNJARO®, ZEPBOUND™, Wegovy®, or Ozempic®. NativeMed does not manufacture medications, practice medicine, or determine whether a specific medication is appropriate for you. Treatment decisions are made by licensed healthcare providers after reviewing your medical history, eligibility, and treatment goals. Information provided by NativeMed is for educational purposes only and should not be interpreted as a claim that any compounded medication is FDA-approved, clinically proven, equivalent to an FDA-approved drug, or guaranteed to produce a specific result, including weight loss. Individual results vary. All medications carry risks, potential side effects, and contraindications and should be used only as prescribed under the supervision of a licensed healthcare provider.

IMPORTANT SAFETY INFORMATION

|

|

|

|

|

|

Copyright © 2026 NativeMed

All Rights Reserved

Limited time discount on

your first order

Sign up to receive health tips and more.

|

NativeMed may facilitate access to compounded medications when prescribed by a licensed healthcare provider and dispensed by a licensed compounding pharmacy. Compounded medications are not approved by the U.S. Food and Drug Administration (FDA), and the FDA does not review compounded medications for safety, effectiveness, or quality before they are dispensed. Compounded medications are prepared for individual patients based on a provider’s medical judgment and are not generic versions of, therapeutically equivalent to, or substitutes for FDA-approved medications such as MOUNJARO®, ZEPBOUND™, Wegovy®, or Ozempic®. NativeMed does not manufacture medications, practice medicine, or determine whether a specific medication is appropriate for you. Treatment decisions are made by licensed healthcare providers after reviewing your medical history, eligibility, and treatment goals. Information provided by NativeMed is for educational purposes only and should not be interpreted as a claim that any compounded medication is FDA-approved, clinically proven, equivalent to an FDA-approved drug, or guaranteed to produce a specific result, including weight loss. Individual results vary. All medications carry risks, potential side effects, and contraindications and should be used only as prescribed under the supervision of a licensed healthcare provider.

IMPORTANT SAFETY INFORMATION

|

|

|

|

|

|

Copyright © 2026 NativeMed

|

All Rights Reserved